Toggle Mobile Navigation

Chairpersons’ Message: 3rd Disclosure and Transparency for Clinical Data Summit

As chairpersons of the 3rd Disclosure and Transparency for Clinical Data Summit, we would like to extend an invitation for you to join us from across the industry to define standardization processes for trial disclosure and registry, provide best practices to balance commercial confidentiality and public access, and examine proven tactics that facilitate data sharing and preserves data usage while ensuring anonymization. We are excited to discuss the tools needed to maximize the benefits of clinical data from the inherent risks of clinical trials, all while complying with national and global disclosure compliance regulations.


The 3rd Disclosure & Transparency for Clinical Data Summit, convening this August 14–15 in Philadelphia, brings together thought leaders from across the country to discuss how to balance your commercial value and ethical responsibilities through the vigilant execution of national and global clinical data transparency.

Attendees will be given the opportunity to recognize the enablers and barriers to success for other organizations. We hope you will take advantage of this opportunity for insights, compelling discussions, and shared perceptions on these topics.

Further details can be found on our website, including information related to the agendapricing, and registration.

This will be an exciting two days, and we look forward to meeting you there.


Karla Childers

Karla Childers, Senior Director, Strategic ProjectsJOHNSON & JOHNSON

Oladayo Oyelola

Oladayo Oyelola, Ph.D., Director, Clinical Trial Information DisclosureDAIICHI SANKYO

posted in ExL Events News

live chat software